Diagrm Tablet


Product Info

Prescription required Yes
Marketer Bal Pharma Ltd
Active Ingredient Gliclazide (40mg) + Metformin (NA) + Rosiglitazone (NA)
Storage Store below 30°C
Habit FormingNo
Therapeutic ClassANTI DIABETIC
User Rating4.6
User Reviews539

FAQ

Diagrm Tablet Reviews

Diagrm belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.

Diagrm is used in the treatment of type 2 diabetes mellitus . It is a combination medicine that can control blood sugar better than single medication. This medicine should be used along with proper diet and regular exercise for best results. It may cause hypoglycemia (low blood sugar level) and weight gain in some patients as a side effect.

How Diagrm Tablet Works

Diagrm is a combination of three antidiabetic medicines: Gliclazide, Metformin and Rosiglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Gliclazide is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Rosiglitazone is a thiazolidinedione which further increases insulin sensitivity.

How to Use Diagrm Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Diagrm is to be taken with food.

Uses of Diagrm Tablet

  • Treatment of Type 2 diabetes mellitus

Diagrm Tablet Side Effects

Item form

Safety Tips

Alcohol  UNSAFE
It is unsafe to consume alcohol with Diagrm.
Driving  CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Breast feeding  CONSULT YOUR DOCTOR
Information regarding the use of Diagrm during breastfeeding is not available. Please consult your doctor.
Liver  CAUTION
Diagrm should be used with caution in patients with liver disease. Dose adjustment of Diagrm may be needed. Please consult your doctor.Inform your doctor if you develop any signs and symptoms of jaundice while taking this medicine.
Kidney  CAUTION
Diagrm should be used with caution in patients with kidney disease. Dose adjustment of Diagrm may be needed. Please consult your doctor.Use of Diagrm is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Pregnancy  CONSULT YOUR DOCTOR
Diagrm may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Quick Tips

  • Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
  • Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, tremor, and anxiety.
  • Take it with food to lower your chance of having an upset stomach.
  • Take it with food to lower your chance of having an upset stomach.
  • Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
  • It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
  • It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
  • Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, tremor, and anxiety.

References

  1. Rosiglitazone. Philadelphia, Pennsylvania: SmithKline Beecham Pharmaceuticals; 1999. [Accessed8 Apr. 2019] (online) Available from:
  2. VilarI L, Canadas V, Arruda MJ, et al. Comparison of metformin, gliclazide MR and rosiglitazone in monotherapy and in combination for type 2 diabetes. Arq Bras Endocrinol Metab. 2010;54(3).
  3. Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company.

Other Medical Preparations